Antimalarial preclinical drug development: a single oral dose of a 5‐carbon‐linked trioxane dimer plus mefloquine cures malaria‐infected mice
Authors:
- 9 December 2009
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 71 (1) , 76-81
Abstract
Three new 5‐carbon‐linked trioxane dimer carboxylate esters have been prepared from the natural trioxane, artemisinin, in only three steps and 40–50% overall yields. Each one of these new chemical entities is at least as efficacious as the clinically used trioxane antimalarial drug artemether when combined with mefloquine hydrochloride in a low single oral dose cure. Drug Dev Res 71: 76–81, 2010.Keywords
This publication has 27 references indexed in Scilit:
- Malaria-Infected Mice Live until at Least Day 30 after a New Monomeric Trioxane Combined with Mefloquine Are Administered Together in a Single Low Oral DoseJournal of Medicinal Chemistry, 2009
- Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural SenegalMalaria Journal, 2009
- Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trialMalaria Journal, 2009
- The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparumMalaria Journal, 2009
- Malaria-Infected Mice Are Cured by a Single Oral Dose of New Dimeric Trioxane Sulfones Which Are Also Selectively and Powerfully Cytotoxic to Cancer CellsJournal of Medicinal Chemistry, 2009
- Synthesis, Antimalarial Activity, and Intracellular Targets of MEFAS, a New Hybrid Compound Derived from Mefloquine and ArtesunateAntimicrobial Agents and Chemotherapy, 2008
- A Convenient Allylic Functionalization of Bis(prop-2-enyl)methanol by Direct TrimetalationSynthesis, 2008
- Drug discovery for malaria: a very challenging and timely endeavorCurrent Opinion in Chemical Biology, 2007
- Second Generation, Orally Active, Antimalarial, Artemisinin-Derived Trioxane Dimers with High Stability, Efficacy, and Anticancer ActivityJournal of Medicinal Chemistry, 2006
- Qinghaosu (Artemisinin): an Antimalarial Drug from ChinaScience, 1985